D-0549-2024 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0549-2024 was initiated by RemedyRepack Inc. on May 31, 2024 and is designated Class II. Reason for recall: Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg. The recall status is terminated (terminated Jul 1, 2024). Affected quantity: 8 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2024
Initiation Date
May 31, 2024
Termination Date
Jul 1, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8 bottles

Product description

Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

Reason for recall

Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

Distribution pattern

Product was distributed to one medical facility.

Code information

Lot # B2906961-042524, exp. date 02/26/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0549-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0549-2024. Report a data issue: hello@regdatalab.com.